Form 4: Hinge Health Director Acquires Class A Stock
Statement of Changes in Beneficial Ownership
Hinge Health Director Tyler Sloat acquired 246 shares of Class A Common Stock through the settlement of vested RSUs on July 5, 2026.
Summary
- Tyler Sloat, a Director at Hinge Health, Inc., acquired 246 shares of Class A Common Stock.
- The acquisition occurred on July 5, 2026, and was a result of the settlement of fully vested restricted stock units (RSUs).
- These RSUs were granted under the Issuer's Non-Employee Director Compensation Program and were elected by the Reporting Person in lieu of quarterly cash retainers.
- The transaction price was $65.847 per share.
- Following this transaction, Mr. Sloat beneficially owns 10,210 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It represents a standard transaction for director compensation and does not inherently signal positive or negative performance, but rather an alignment of interests.
Positives
- Director acquisition of company stock can signal confidence in the company's future prospects.
- The acquisition was made through vested RSUs, indicating prior compensation arrangements were fulfilled.
- The shares were acquired at a stated price of $65.847, providing a clear valuation point for this portion of the transaction.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership by a director.
Industry Context
StockSavvy.ai notes that director stock acquisitions, particularly through RSU settlements, are common within the health technology sector as a method of aligning executive and director interests with shareholder value. The price of $65.847 per share provides a data point for valuation within this specific sub-sector.
Stakeholder Impact
- Shareholders: The acquisition by a director may be viewed positively as it aligns director interests with those of shareholders. The specific price of $65.847 provides transparency.
- Employees: The RSU settlement reflects the company's compensation structure for non-employee directors, which is part of the overall corporate governance framework.
- Management: The transaction is a routine reporting event for management and the board.
Key Dates
| Date | Description |
|---|---|
| 07/05/2026 | Earliest transaction date and date of RSU settlement. |
| 07/07/2026 | Date of signature for the filing. |
Keywords
Hinge Health, Tyler Sloat, Form 4, Class A Common Stock, Restricted Stock Units, RSUs, Director Compensation, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.